Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Correction

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil

Juliana G Assumpção1, Ana Luíza Seidinger1, Maria José Mastellato1, Raul C Ribeiro23, Gerard P Zambetti4, Ramapriya Ganti5, Kumar Srivastava6, Sheila Shurtleff5, Deqing Pei6, Luiz Carlos Zeferino7, Rozany M Dufloth8, Silvia Regina Brandalise1 and José Andres Yunes1*

Author Affiliations

1 Centro Infantil Boldrini, Campinas, Brazil

2 Department of Oncology, St. Jude Children's Research Hospital, Memphis, USA

3 International Outreach Program, St. Jude Children's Research Hospital, Memphis, USA

4 Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, USA

5 Department of Pathology, St. Jude Children's Research Hospital, Memphis, USA

6 Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, USA

7 Universidade Estadual de Campinas, Campinas, Brazil

8 Universidade Federal de Santa Catarina, Florianópolis, Brazil

For all author emails, please log on.

BMC Cancer 2011, 11:152  doi:10.1186/1471-2407-11-152


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2407/11/152


Received:13 April 2011
Accepted:26 April 2011
Published:26 April 2011

© 2011 Assumpção et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Correction

Of the 123 patients included in our work [1], 44 were selected according to the following familial risk history criteria: early onset (less than 35 years of age); bilateral carcinoma; more than three cases of breast cancer and more than one case of ovarian cancer in the family; more than two first degree relatives involved; and male breast cancer. We regret that in the methods section of our manuscript [1], it was erroneously stated both that the number of patients with familial history was 45 and that the criteria used for their selection was: "had either more than three cases of breast cancer and more than one case of ovarian cancer in the family; or had more than two first-degree relatives with breast cancer; or had one case of male breast cancer" (only two out of these 44 patients would have fulfilled these criteria).

Fortunately, the information regarding the familial history of our breast cancer patients was added for descriptive reasons and was not a part of any results, statistical analysis or conclusions.

References

  1. Assumpção JG, Seidinger AL, Mastellaro MJ, Ribeiro RC, Zambetti GP, Ganti R, Srivastava K, Shurtleff S, Pei D, Zeferino LC, Dufloth RM, Brandalise SR, Yunes JA: Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.

    BMC Cancer 2008, 8:357. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2407/11/152/prepub